Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
54,405,738
-
Total 13F shares
-
31,699,756
-
Share change
-
+3,032,105
-
Total reported value
-
$259,632,936
-
Price per share
-
$8.19
-
Number of holders
-
65
-
Value change
-
+$20,698,081
-
Number of buys
-
43
-
Number of sells
-
20
Institutional Holders of Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) as of Q4 2024
As of 31 Dec 2024,
Zenas BioPharma, Inc. - Common Stock, $0.0001 par value per share (ZBIO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,699,756 shares.
The largest 10 holders included
SR One Capital Management, LP, Enavate Sciences GP, LLC, NEA Management Company, LLC, Fairmount Funds Management LLC, NVP Associates, LLC, FMR LLC, Novo Holdings A/S, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Vivo Capital, LLC, and FEDERATED HERMES, INC..
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.